Skip to content

The effect of pain control pump for postoperative cuff repair

The effect of 1st day postoperative cuff repair pain control pump on the intensity of sub-acute 2 weeks pain

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20091117002723N3
Enrollment
70
Registered
2023-05-18
Start date
2023-06-01
Completion date
Unknown
Last updated
2023-05-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Rupture of rotator cuff tendon. Rotator cuff tear or rupture, not specified as traumatic

Interventions

Intervention 1: Intervention group (first group): the Intervention patient will be given medications to help relieve symptoms on the first 24 hours after surgery. So, pain control pump will be given (
if the pain score is greater than or equal to 4.). Control patients will be blinded to the injection of placebo pain control pump (IV PCA) with the same volume and appearance as group 1, containing no

Sponsors

Shiraz University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
30 Years to 70 Years

Inclusion criteria

Inclusion criteria: Adult patients with ASA grade I or II (American Society of Anesthesiology classification) patients between 30 and 70 years old Patients who candidate for rotator cuff surgery

Exclusion criteria

Exclusion criteria: Allergy to the drugs used in the study Positive history of chemotherapy and radiotherapy Positive history of liver, kidney, hormone problems, central nervous system disorders and diseases, depression and anxiety Addiction to drugs, alcohol and smoking Use of Corticosteroid and Benzodiazepine pregnancy

Design outcomes

Primary

MeasureTime frame
Pain. Timepoint: Every 10 minutes during recovery, 6 hours, 12 hours, 24 hours, 48 hours, one week, ten days and two weeks after the end of the intervention. Method of measurement: Questionnaire and Numerical Pain Rating Scale (NRS).

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMahshid Hashemi nasab

Shiraz University of Medical Sciences

hasheminasabm@yahoo.com+98 71 3647 4270

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026